JOURNAL OF RHEUMATOLOGY风湿病学杂志

JOURNAL OF RHEUMATOLOGY(英文缩写 J RHEUMATOL),ISSN 0315-162X,eISSN 1499-2752,中文译名:风湿病学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
3.700
JCR 分区
Q2
CAS 分区
B3
近一年发文量
363
本站 PubMed 收录统计

发文量统计区间:2025-09-27 至 2026-09-27,按本站收录文献的发表日期统计。

ISSN: 0315-162X · eISSN: 1499-2752 · 缩写: J RHEUMATOL ·中文: 风湿病学杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《The Journal of Rheumatology》是国际风湿病学领域的老牌同行评议期刊,面向风湿科医师、临床研究人员及相关学科工作者。内容覆盖炎症性关节病、自身免疫性结缔组织病、脊柱关节病、骨关节炎与代谢性骨病等,兼顾临床诊疗与转化研究。除原创论著外,还刊载综述、病例讨论、影像与临床实践类文章,强调研究结果对日常风湿病管理的参考价值,读者群以临床医生和临床研究者为主。

研究方向

主要方向包括类风湿关节炎、系统性红斑狼疮、血管炎、银屑病关节炎、痛风与晶体性关节病、骨质疏松及风湿病相关合并症。论文类型以临床研究、队列与观察性研究、随机对照试验、诊断与预后研究、系统综述和病例报告为主,也接受发病机制与生物标志物等转化医学研究,以及影像学和治疗策略评估类稿件。

期刊特色

研究取向偏重临床问题导向,强调研究设计规范、数据真实和结论对实践的可操作性。论文通常要求明确的患者人群、结局指标和统计学处理,对样本量与随访完整性有一定要求。适合有稳定病例资源、能开展多中心或长期随访的临床团队,也适合希望将机制发现转化为临床提示的研究者。

投稿难度

投稿难度中等偏上,对临床研究的创新性、方法学严谨性和英文表达要求较高。仅凭分区难以判断录用前景,建议先明确研究问题与目标读者,完善统计分析和伦理说明,规范报告格式,并在投稿前请同行评阅。若为单中心小样本或重复性研究,宜补充机制探索或长期随访数据以增强说服力。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20215.346Q2
20223.900Q2
20233.600Q2
20243.400Q2
20253.700Q2

JOURNAL OF RHEUMATOLOGY 最新收录文献

  1. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    1. Phoenixin-14 as a Potential Limiting Neuropeptide for Exaggerated Inflammation in Familial Mediterranean Fever and Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis: A Comparative Study.

    作者:
    Semra Ayduran, Gülşah Kılbaş, Saadet Nilay Tığrak, İlknur Kaleli, Melek Demir, Serkan Türkuçar
    日期:
    2026-09-17

    This study aimed to evaluate serum phoenixin-14 (PNX-14) levels in patients with familial Mediterranean fever (FMF) and periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) during both attack and attack-free periods to investigate its potential biomarker value. In total, 140 children were included in this cross-sectional study: 46 with FMF, 48 with PFAPA, and 46 healthy children. Blood samples were collected during both febrile and attack-free periods in the patients with FMF and PFAPA, whereas samples from healthy controls were collected at a single timepoint. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum amyloid A (SAA), fibrinogen, and serum PNX-14 levels were evaluated. Serum PNX-14 levels were measured using ELISA. SPSS 25 (IBM) was used for statistical analyses. PNX-14 levels were significantly higher during attack periods in FMF and PFAPA patients compared to attack-free periods and healthy controls ( < 0.001). PNX-14 levels during attack-free periods were also higher in both patient groups than in healthy controls ( < 0.001). Although a positive correlation was observed between PNX-14 levels and CRP (ρ 0.222, = 0.04), no significant correlation was observed with ESR, SAA, or fibrinogen. No significant associations were observed between PNX-14 levels and disease severity (Pras disease severity score), colchicine treatment duration, or daily colchicine dose in the FMF group. PNX-14 may be part of a neuroimmune response aimed at resolving inflammation in autoinflammatory processes and could be a potential immunomodulatory biomarker. PNX-14 may be a complementary indicator reflecting inflammatory burden or the healing process.

  2. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    2. Clinical features and a Nomogram for predicting clinical response in juvenile dermatomyositis associated interstitial lung disease.

    作者:
    Xinwei Shi, Junmei Zhang, Shipeng Li, Xiaohua Tan, Li Li, Jianghong Deng, Weiying Kuang, CaiFeng Li
    日期:
    2026-09-15

    Juvenile dermatomyositis (JDM) is a rare autoimmune disease and accompany by interstitial lung disease (ILD), a major cause of morbidity and mortality. However, data on clinical features and prognosis of JDM-ILD in Chinese pediatric populations remain limited. The aim is to characterize the clinical features, treatment options and prognosis of JDM-ILD in Chinese pediatric patients, and to develop a nomogram for predicting clinical response. We retrospectively enrolled 244 JDM-ILD patients from Beijing Children's Hospital (May 2015-January 2026). Demographic, clinical, laboratory, treatment, and prognostic data were collected. Clinical response was assessed through a combination of PRINTO-defined clinical inactive disease (CID) , respiratory symptoms and HRCT. Independent prognostic factors were identified using Cox regression analysis and incorporated into a nomogram. Model performance was assessed using C-index, calibration curves and decision curve analysis (DCA). Among 244 patients (55.7% female, median onset age 5.7 years), anti-MDA5 (32.0%) and anti-NXP2 (13.9%) were the most prevalent autoantibodies. At last follow-up visit, 202 patients (82.8%) achieved CID, with CID rates increasing progressively over time. A total of three patients who tested positive for anti-MDA5 antibody died of RP-ILD (median survival 2.7 months). Multivariable Cox regression identified combination therapy with JAK inhibitors (HR 2.09, 95%CI 1.25-3.50) or IL-6 inhibitors (HR 1.83, 95%CI 1.07-3.12) and Gottron's sign (HR 1.80, 95%CI 1.10-2.96) as favorable factors for CID, while high-risk status (HR 0.23, 95%CI 0.10-0.57), higher DAS skin score (HR 0.71, 95%CI 0.48-1.00), and higher neutrophil-to-lymphocyte ratio (NLR) (HR 0.84, 95%CI 0.72-0.97) predicted lower probability of CID. The nomogram showed predictive performance in both training cohort (AUC: 0.67, 0.77, and 0.78 at 1, 3, and 5 years) and testing cohort (AUC: 0.60, 0.78 and 0.77 at 1, 3, and 5 years). This nomogram for predicting clinical response in Chinese pediatric JDM-ILD patients integrates clinical features and treatment variables to enable individualized risk stratification. Combination therapy with JAK or IL-6 inhibitors demonstrates promising efficacy and may improve outcomes.

  3. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    3. Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology Study- Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions.

    作者:
    Seyyid Bilal Acikgoz, Ummugulsum Gazel, Suharsh Shah, Rohan Apurva Machhar, Patrick Leclerc, Marie Maguin, Gurjit S Kaeley, Lihi Eder, Sibel Zehra Aydin
    日期:
    2026-09-15

    Ultrasonography (US) is essential in rheumatology, but conventional systems are costly and not easily portable. Handheld US offers affordable, portable options, yet their diagnostic validity in Psoriatic Arthritis (PsA) is unclear. This study assessed the concurrent validity of handheld US devices in PsA by evaluating agreement with a gold-standard scanner in detecting elementary lesions. PsA patients meeting Classification Criteria for PsA and presenting ≥ tender and swollen joint underwent same-day US with handheld (Clarius-HD3 L20/L15) and gold-standard (GE Logiq E9/E10) systems using a standardized protocol. A blinded assessor scored anonymized images for synovitis, Doppler signals, erosions, and tendon/tenosynovitis based on OMERACT definitions. Inter-device agreement was analyzed using Cohen's kappa (lesion detection), weighted kappa (lesion scoring), and intraclass correlation (ICC) per patient. Thirty patients were included. Between devices, agreement for detecting synovitis was moderate (κ = 0.46-0.50). For Doppler activity, moderate agreement was found with Clarius-L15 (κ = 0.42) and fair agreement with Clarius-L20 (κ = 0.37). Erosions showed moderate-to-substantial agreement (κ for L15= 0.57, L20= 0.62), whereas tendon inflammation had no-fair (κ for L15=0.16, -0.05). Per-patient agreement showed poor (Global OMERACT-EULAR Synovitis Score - GLOESS) and moderate agreement (Doppler) for L15, and good (GLOESS) and moderate (Doppler) agreement for L20, when compared with the gold-standard device. Handheld US devices demonstrated moderate agreement with high-end scanners in identifying and grading synovitis and erosions, suggesting promising potential for clinical application. However, sensitivity for Doppler activity and tendon lesions remains lower, emphasizing the need for continued optimization and validation.

  4. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    4. What Defines an MRI Considered Indicative of Axial Spondyloarthritis in the Sacroiliac Joints: A Systematic Literature Review.

    作者:
    Mohamad Bittar, Majid Chalian, Natalya Horbal, Liron Caplan, Maureen Dubreuil, Parham Pezeshk, Rachael Stovall, Janice Y Kung, Lianne S Gensler, Atul Deodhar, Robert G W Lambert, Walter P Maksymowych
    日期:
    2026-09-15

    To systematically review the literature to support guidance defining MRI criteria of sacroiliac joint (SIJ) involvement indicative of axial spondyloarthritis (axSpA) for classification. The primary question for the SLR was 'Which MRI lesion, or combination of lesions, in the SIJ is most sensitive and specific for an MRI considered indicative of axSpA'. Three additional questions addressed an endpoint of clinician diagnosis of axSpA and the extent and location of the lesion(s). The SLR included all studies from January 2017 through October 2025, and 5 databases (Scopus, Web of Science Core Collection, Ovid MEDLINE, Ovid Embase, and Cochrane Library (via Wiley)) were searched. Data extraction and risk of bias assessment was done independently by three reviewers. Searches returned 1871 unique results, of which 30 were selected for full review and data extraction. Only 2 reports described 'MRI global indicative of axSpA' as reference criterion and only 5 assessed MRI lesion definitions in an inception cohort study design. The quantitative component for bone marrow edema (BME) of the ASAS 2009/2016 MRI definitions lacked specificity. BME in <4 SIJ quadrants was seen in anterior SIJ slices of peripartum women, and healthy individuals. Erosion and fat lesion were uncommon (<5%) in healthy individuals and disorders that mimic axSpA. BME adjacent to erosion and/or fat lesion was highly specific for axSpA. The quantitative cut-offs of active and structural lesions are derived from a single inception cohort, which would require future studies for external validation. These results reinforce the need to revise previously reported definitions of a positive MRI indicative of axSpA towards more stringent cut-offs that detail the extent and location of MRI lesions.

  5. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    5. Drs. Wei and Mo reply.

    作者:
    Xiuning Wei, Yingqian Mo
    日期:
    2026-09-15

    该文献暂无摘要。

  6. JCR分区: Q2 CAS分区: B3 影响因子: 3.7
  7. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    7. Dr. Schock et al reply.

    作者:
    Bettina C Schock, Rosa I Rodríguez Viera, Steven O'Reilly, Nazia Chaudhuri
    日期:
    2026-09-15

    该文献暂无摘要。

  8. JCR分区: Q2 CAS分区: B3 影响因子: 3.7
  9. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    9. Unity Through Rheumatic Diseases: A Youth-Led Model of Community, Connection, and Change.

    作者:
    Natasha Trehan, Brianne Chou, Maggie Douglas, Isabel Dukes, Yaneisy-Nynoska Tremblay, Nicholas Blanchette, Nadia Luca, Mark Matsos, Yan Yeung, Reine Hodroj, Andrea Ou-Hingwan, Natalia Trehan, Zac Spinosa, Michelle Batthish, Andrea Knight, Rae Yeung, Deborah A Marshall, Cheryl Barnabe, Cristina Montoya, Cheryl Crow
    日期:
    2026-09-15

    该文献暂无摘要。

  10. JCR分区: Q2 CAS分区: B3 影响因子: 3.7

    10. Multidimensional Complexities of Rheumatoid Arthritis Care.

    10. 类风湿关节炎护理的多维复杂性
    作者:
    Pedro Santos-Moreno
    日期:
    2026-09-15

    该文献暂无摘要。

在 JOURNAL OF RHEUMATOLOGY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊